Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02126774 · ClinicalTrials.gov registry record
The Human Epilepsy Project
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 488
- Enrollment target
NCT02126774 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 488 participants.
The verdict
NCT02126774 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 488 participants
- Enrollment target
Study Summary
HEP is a five-year, prospective, observational study whose primary goal is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in participants with newly treated focal epilepsy.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 488 participants |
| Start Date | 2012-07 |
| Est. Completion | 2021-07-01 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02126774
The ClinicalTrials.gov registry entry for NCT02126774 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 488 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT02126774 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02126774 about?
NCT02126774 is a clinical study titled "The Human Epilepsy Project". HEP is a five-year, prospective, observational study whose primary goal is to identify clinical characteristics and biomarkers predictive of disease outcome, progression, and treatment response in participants with newly treated focal epilepsy.
What is the current status of trial NCT02126774?
This trial is currently completed. The enrollment target is 488 participants. The study started on 2012-07. Estimated completion is 2021-07-01.
Who is sponsoring clinical trial NCT02126774?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.